Specialty Pharma Journal Specialty, Precision & Technology

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Acceleron Pharma Inc. (NASDAQ:XLRN), a leading biopharmaceutical company in the discovery and development …

NEW YORK, Sept. 16, 2019 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix …

VALBY, Denmark and BOTHELL, Wash., Sept. 16, 2019 (GLOBE NEWSWIRE) — H. Lundbeck A/S (Lundbeck) …

BOTHELL, Wash. & TOKYO–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji …

CAMBRIDGE, Mass., Sept. 16, 2019 (GLOBE NEWSWIRE) —  Wave Life Sciences Ltd. (Nasdaq: WVE), a …

SALT LAKE CITY, Sept. 16, 2019 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader …

DUBLIN and BAGSVÆRD, Denmark, Sept. 16, 2019 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT), and Novo Nordisk A/S today …

WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca today announced that the US Food and Drug Administration (FDA) has granted …

HORSHAM, Pa., Sept. 16, 2019 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson …

WOODCLIFF LAKE, N.J., Sept. 13, 2019 /PRNewswire/ — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo …

THOUSAND OAKS, Calif., Sept. 13, 2019 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced the Phase 3 CANDOR study evaluating KYPROLIS® (carfilzomib) …

NEW YORK and LONDON, Sept. 13, 2019 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), …

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: …

EXTON, Pa., Sept. 12, 2019 (GLOBE NEWSWIRE) — Fibrocell Science, Inc. (Nasdaq: FCSC), a cell …

SUMMIT, N.J.–(BUSINESS WIRE)–Celgene Corporation (NASDAQ: CELG) today announced top-line results from the international phase 3, …